Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01379664 · ClinicalTrials.gov registry record · NA
Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project
A NA study of Duration of Hospitalization, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,584
- Enrollment target
- 1
- Study location
NCT01379664: Completed NA study of Duration of Hospitalization, sponsored by The Cleveland Clinic.
NCT01379664 is a NA study of Duration of Hospitalization that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,584 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01379664, a NA study of Duration of Hospitalization, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,584 participants
- Enrollment target
- 1
- Study location
Study Summary
Preliminary retrospective data suggest that the relatively soluble but inexpensive volatile anesthesia isoflurane prolongs the duration of hospitalization compared to the less soluble but more expensive anesthetic sevoflurane. Even a small reduction in the duration of hospitalization would easily compensate for the modest additional cost of sevoflurane. The investigators therefore propose to test the primary hypothesis that duration of hospitalization is longer with isoflurane than sevoflurane. The investigators will also test the secondary hypotheses that: 1) pain scores are greater in patients recovering from isoflurane than sevoflurane anesthesia; and, 2) opioid consumption is greater after isoflurane than sevoflurane anesthesia. All statistical analyses will be adjusted for age, gender, race, baseline risk, 9 and procedure.
Conditions Studied
Interventions
- DRUG Sevoflurane
- DRUG Isoflurane
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,584 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01379664 record still lists
NCT01379664 is an interventional study that assigns participants to a tested intervention. Its 1,584 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Duration of Hospitalization appearing as the primary indexed condition, and to 2 interventions - of which Sevoflurane is the first listed.
NCT01379664 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01379664 about?
NCT01379664 is a clinical study titled "Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project". Preliminary retrospective data suggest that the relatively soluble but inexpensive volatile anesthesia isoflurane prolongs the duration of hospitalization compared to the less soluble but more expensive anesthetic sevoflurane. Even a small reduction in the duration of hospitalization would easily co...
What is the current status of trial NCT01379664?
This trial is currently completed. It is a NA study. The enrollment target is 1,584 participants. The study started on 2011-07. Estimated completion is 2013-04.
What conditions does trial NCT01379664 study?
This clinical trial studies the following conditions: Duration of Hospitalization.
What interventions are being tested in trial NCT01379664?
The interventions under investigation include: Sevoflurane (DRUG), Isoflurane (DRUG).
Who is sponsoring clinical trial NCT01379664?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01379664 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01379664's enrollment target sits among peer trials
1,584 64th of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT05552222 · 1,590 participants · Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- NCT06632457 · 1,590 participants · Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- NCT05243797 · 1,594 participants · Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia